Sciton Launches mJOULE in Canada

Sciton Inc. is launching the new mJOULE platform in Canada.  This system features the company's newest fractional treatment MOXI and BBL HERO treatment.

"Part of Sciton's global growth strategy is to ensure our partners and their patients have access to a fantastic treatment experience that delivers exactly what's promised," says Robb Brindley, Vice President of Sales, North America, in a news release. "Today we further that mission by extending the mJOULE platform to Canada, a burgeoning aesthetic market which has gained tremendous momentum over the past few years. We are thrilled to bring this novel platform and its sought after treatments to millions of Canadians through our network of leading providers."

The mJOULE dual modality platform features BBL HERO and MOXI technologies, which were created in response to a changing market which desires less time consuming treatments, yet equally strong outcomes.

BBL HERO (High Energy Rapid Output) can treat the entire body with four times the speed and three times the peak intensity, allowing for highly customizable protocols. The treatment can provide smoother, clearer, younger and healthier looking skin in just one to two sessions. 

Sciton's MOXI ensures a safe treatment experience for those higher on the Fitzpatrick scale, which in the past has typically been at risk for hyperpigmentation when undergoing laser treatments. This non-ablative laser safely addresses sun damage and aging, takes under 20 minutes, boasts little to no social downtime and can be performed any time of the year.

"We have a loyal customer base in Canada and I am thrilled to aid in strengthening Sciton's presence and relationship with its globally recognized aesthetic leaders," adds Canadian Director, Andrew Hrytzak. "Our Canadian team is confident that mJOULE will satisfy a current gap in the market by providing stronger results far beyond the face and decolletage, for a larger population, in a fraction of the time."